HPAF-II SMAD/TGFbeta Reporter (Luc) stable cell line
Catalog number
CL-1473
Description
HPAF-II SMAD/TGFbeta Reporter (Luc) cells are derived from the human pancreas adenocarcinoma HPAF-II cell line by stably integration of a SMAD/TGFbeta firefly luciferase reporter construct. HPAF-II cell line has been widely to study pancreatic cancer biology, test new drugs, and explore potential treatments. HPAF-II SMAD/TGFbeta Reporter (Luc) cells stably express firefly luciferase under the control of the SMAD/TGFbeta response elements, can be used for monitoring the activity of TGFβ/SMAD signaling pathway.